年轻结直肠癌患者临床特征及诊疗进展

doi:10.3760/cma.j.issn.1673-422X.2017.04.018

摘要/Abstract

摘要： 结直肠癌为消化道最常见肿瘤之一，年轻结直肠癌患者与其他年龄段的结直肠癌患者在疾病特点、生物学特点、危险因素、临床诊治和生存预后等方面有所差别，分析年轻结直肠癌患者的特点可为其治疗提供新的思路。

Abstract: Colorectal cancer is one of the most common malignant tumors of digestive system. There are significant differences between young patients and other ages in aspects of the disease features, biological characteristics, risk factors, clinical treatment and prognosis, etc. And the analysis of young colorectal cancer patients′ characteristics can provide new ideas for clinical treatment.

Key words: Colorectal neoplasms, Age groups

闫洪凯,刘朝旭,宋宁,史留斌. 年轻结直肠癌患者临床特征及诊疗进展[J]. 国际肿瘤学杂志, 2017, 44(4): 307-309.

Yan Hongkai, Liu Chaoxu, Song Ning, Shi Liubin. Clinical characteristics and treatment progress of adolescent and young adult with colorectal cancer[J]. Journal of International Oncology, 2017, 44(4): 307-309.

参考文献

［1］ Kansakar P, Singh Y. Changing trends of colorectal carcinoma in nepalese young adults［J］. Asian Pac J Cancer Prev, 2012, 13(7): 3209-3212. ［2］ Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975—2010［J］. JAMA Surg, 2015, 150(1): 17-22. DOI: 10.1001/jamasurg.2014.1756. ［3］ Smith AW, Seibel NL, Lewis DR, et al. Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future［J］. Cancer, 2016, 122(7): 988-999. DOI: 10.1002/cncr.29870. ［4］ Tricoli JV, Blair DG, Anders CK, et al. Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma［J］. Cancer, 2016, 122(7): 1017-1028. DOI: 10.1002/cncr.29871. ［5］ Zhu C, Ji M, Dai W, et al. Clinicopathological characteristics of Chinese colorectal cancer patients under 30 years old: implication in diagnosis and therapy［J］. Curr Cancer Drug Targets, 2015, 15(1): 2734. ［6］ Wang MJ, Ping J, Li Y, et al. The prognostic factors and multiple biomarkers in young patients with colorectal cancer［J］. Sci Rep, 2015， 5: 10645. DOI: 10.1038/srep10645. ［7］ Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young-onset colorectal cancer［J］. World J Gastroenterol, 2016, 22(5): 1736-1744. DOI: 10.3748/wjg.v22.i5.1736. ［8］ Stigliano V, Sanchez-Mete L, Martayan A, et al. Early-onset colorectal cancer: a sporadic or inherited disease?［J］. World J Gastroenterol, 2014, 20(35): 12420-12430. DOI: 10.3748/wjg.v20.i35.12420. ［9］ Provenzale D, Gupta S, Ahnen DJ, et al. Genetic/familial high-risk assessment: colorectal version 1.2016, NCCN clinical practice guidelines in oncology［J］. J Natl Compr Canc Netw, 2016, 14(8): 1010-1030. ［10］ You YN, Xing Y, Feig BW, et al. Young-onset colorectal cancer: is it time to pay attention?［J］. Arch Intern Med, 2012, 172(3): 287-289. DOI: 10.1001/archinternmed.2011.602. ［11］ Davis DM, Marcet JE, Frattini JC, et al. Is it time to lower the recommended screening age for colorectal cancer?［J］. J Am Coll Surg, 2011, 213(3): 352-361. DOI: 10.1016/j.jamcollsurg.2011.04.033. ［12］ Liang JT, Huang KC, Cheng AL, et al. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age［J］. Br J Surg, 2003, 90(2): 205-214. ［13］ Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action［J］. Mayo Clin Proc, 2014, 89(2): 216-224. DOI: 10.1016/j.mayocp.2013.09.006. ［14］ Perea J, Rueda D, Canal A, et al. Age at onset should be a major criterion for subclassification of colorectal cancer［J］. J Mol Diagn, 2014, 16(1): 116-126. DOI: 10.1016/j.jmoldx.2013.07.010. ［15］ Young JP, Win AK, Rosty C, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review［J］. J Gastroenterol Hepatol, 2015, 30(1): 6-13. DOI: 10.1111/jgh.12792. ［16］ Franceschi S, Favero A, La VC, et al. Food groups and risk of colorectal cancer in Italy［J］. Int J Cancer, 1997, 72(1): 56-61. ［17］ Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States［J］. Cancer Epidemiol Biomarkers Prev, 2009, 18(6): 1695-1698. DOI: 10.1158/1055-9965. ［18］顾飞英, 袁瑛. 肿瘤分子标志物与个体化治疗［J］. 国际肿瘤学杂志, 2012, 39(6): 428-431. DOI: 10.3760/cma.j.issn.1673-422X.2012.06. 009. ［19］ Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Localized colon cancer, version 3.2013: featured updates to the NCCN guidelines［J］. J Natl Compr Canc Netw, 2013, 11(5): 519-528. ［20］ Inra JA, Syngal S. Colorectal cancer in young adults［J］. Dig Dis Sci, 2015, 60(3): 722-733. DOI: 10.1007/s10620-014-3464-0. ［21］ O′Connell JB, Maggard MA, Livingston EH, et al. Colorectal cancer in the young［J］. AM J Surg, 2004, 187(3): 343-348. ［22］ Teng A, Lee DY, Cai J, et al. Patterns and outcomes of colorectal cancer in adolescents and young adults［J］. J Surg Res, 2016, 205(1): 19-27. DOI: 10.1016/j.jss.2016.05.036. ［23］ Haggar FA, Preen DB, Pereira G, et al. Cancer incidence and mortality trends in Australian adolescents and young adults, 1982—2007［J］. BMC Cancer, 2012, 12(1): 151. DOI: 10.1186/1471-2407-12-151. ［24］ Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer［J］. Ann Surg Oncol, 2007, 14(10): 2759-2765. DOI: 10.1245/s10434-007-9465-x. ［25］ Gondos A, Hiripi E, Holleczek B, et al. Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison［J］. Int J Cancer, 2013, 133(9): 2207-2215. DOI: 10.1002/ijc.28231. ［26］ Kumar S, Burney IA, Zahid KF, et al. Colorectal cancer patient characteristics, treatment and survival in Omana—a single center study［J］. Asian Pac J Cancer Prev, 2015, 16(12): 4853-4858. ［27］ Wang R, Wang MJ, Ping J. Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988-2011)［J］. Medicine (Baltimore), 2015, 94(35): e1402. DOI: 10.1097/MD.0000000000001402. ［28］ Vatandoust S, Price T J, Ullah S, et al. Metastatic colorectal cancer in young adults: a study from the south Australian population-based registry［J］. Clin Colorectal Cancer, 2016, 15(1): 32-36. DOI: 10.1016/j.clcc.2015.07.005. ［29］ Park SK, Kim NH, Jung YS, et al. Risk of developing advanced colorectal neoplasia after removing high-risk adenoma detected at index colonoscopy in young patients: a KASID study［J］. J Gastroenterol Hepatol, 2016, 31(1): 138-144. DOI: 10.1111/jgh.13167.

[1]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[2]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[3]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	刘德宝, 孙子雯, 鲁守堂, 徐海东. ASB6在结直肠癌组织中的表达及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 470-474.
[6]	陈卓, 陶俊, 陈琳, 柯晶. 外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273.
[7]	黄镇, 张蔡羽天, 柯少波, 石薇, 赵文思, 陈永顺. 结直肠癌患者术后预后模型的构建[J]. 国际肿瘤学杂志, 2023, 50(3): 157-163.
[8]	徐良富, 李袁飞. MSS型结直肠癌肿瘤微环境及免疫联合治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(3): 186-190.
[9]	刘玉杰, 赵志强, 王子琤. 早期结直肠癌患者外周血单个核细胞中TOP2A、ERBB2的水平及其诊断价值[J]. 国际肿瘤学杂志, 2023, 50(12): 717-722.
[10]	陶红, 殷红, 罗宏, 陶佳瑜. 靶向肿瘤相关巨噬细胞增强结直肠癌免疫检查点抑制剂疗效的潜在策略[J]. 国际肿瘤学杂志, 2023, 50(11): 683-687.
[11]	王熙, 吴川清. 结直肠癌多药耐药逆转的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 42-46.
[12]	高一钊, 刘洋, 刘秋龙, 邢金良. 循环游离核酸在结直肠癌临床诊疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(9): 555-559.
[13]	何哲锋, 吴燚阳, 李振军, 应晓江. 炎性相关标志物对结直肠癌的预测价值[J]. 国际肿瘤学杂志, 2022, 49(9): 560-563.
[14]	赵莹, 张革红. AGR、PLR及NLR变化与转移性结直肠癌化疗疗效的相关性研究[J]. 国际肿瘤学杂志, 2022, 49(8): 473-477.
[15]	黄梦盼, 王学红, 芦永福. FOXA2在结直肠癌中的作用机制及其在诊疗中的作用[J]. 国际肿瘤学杂志, 2022, 49(8): 490-493.